Adverse side effects make the Janssen vaccine an option of last resort. Emergency use authorization guidelines for Johnson & Johnson’s COVID-19 vaccine, labeled as Janssen, and reported with CPT® code 91303, have changed. The U.S. Food and Drug Administration now limits authorized use of the vaccine to “individuals 18 years of age and older for […]
The post FDA Limits J&J’s COVID-19 Vaccine appeared first on AAPC Knowledge Center.